Phil Zamore
E446843
Phil Zamore is a molecular biologist and biotechnology entrepreneur best known as a co-founder of Alnylam Pharmaceuticals and a pioneer in the field of RNA interference therapeutics.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Phil Zamore canonical | 2 |
How this entity was disambiguated
This entity first appeared as the object of triple T4492404 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Phil Zamore Context triple: [Alnylam Pharmaceuticals, foundedBy, Phil Zamore]
-
A.
Shawn Maurer
Shawn Maurer is a film cinematographer known for his work on parody and comedy movies, including the spoof film "Disaster Movie."
-
B.
Jeff McIlwain
Jeff McIlwain is an electronic music producer and film composer best known for his work under the moniker Lusine, blending ambient, techno, and experimental sounds.
-
C.
Richard Tuggle
Richard Tuggle is an American screenwriter and director best known for his work on the Clint Eastwood films "Escape from Alcatraz" and "Tightrope."
-
D.
Kenny Dillingham
Kenny Dillingham is an American college football coach known for his offensive expertise and for serving as the head coach of the Arizona State Sun Devils.
-
E.
Darius N. Couch
Darius N. Couch was a Union Army major general during the American Civil War, noted for his corps command in key Eastern Theater campaigns.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Phil Zamore Target entity description: Phil Zamore is a molecular biologist and biotechnology entrepreneur best known as a co-founder of Alnylam Pharmaceuticals and a pioneer in the field of RNA interference therapeutics.
-
A.
Shawn Maurer
Shawn Maurer is a film cinematographer known for his work on parody and comedy movies, including the spoof film "Disaster Movie."
-
B.
Jeff McIlwain
Jeff McIlwain is an electronic music producer and film composer best known for his work under the moniker Lusine, blending ambient, techno, and experimental sounds.
-
C.
Richard Tuggle
Richard Tuggle is an American screenwriter and director best known for his work on the Clint Eastwood films "Escape from Alcatraz" and "Tightrope."
-
D.
Kenny Dillingham
Kenny Dillingham is an American college football coach known for his offensive expertise and for serving as the head coach of the Arizona State Sun Devils.
-
E.
Darius N. Couch
Darius N. Couch was a Union Army major general during the American Civil War, noted for his corps command in key Eastern Theater campaigns.
- F. None of above. chosen
Statements (37)
| Predicate | Object |
|---|---|
| instanceOf |
academic
ⓘ
biotechnology entrepreneur ⓘ molecular biologist ⓘ scientist ⓘ |
| associatedWith |
Alnylam’s early scientific strategy
ⓘ
RNAi therapeutics industry ⓘ |
| coFounded | Alnylam Pharmaceuticals ⓘ |
| countryOfCitizenship |
United States
ⓘ
linked to:
United States of America
|
| fieldOfWork |
RNA biology
ⓘ
RNA interference ⓘ RNA therapeutics ⓘ gene silencing ⓘ molecular biology ⓘ |
| hasAcademicDiscipline |
RNA biochemistry
ⓘ
biochemistry ⓘ molecular genetics ⓘ |
| hasContribution |
elucidation of biochemical steps in RNAi pathways
ⓘ
translation of RNAi from basic science to drug development ⓘ |
| hasNotableStudentOrTrainee | RNA interference researchers ⓘ |
| hasOccupation |
biotech founder
ⓘ
professor ⓘ research scientist ⓘ |
| hasRole | co-founder of Alnylam Pharmaceuticals ⓘ |
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| influenced | development of RNAi as a therapeutic modality ⓘ |
| knownFor |
co-founding Alnylam Pharmaceuticals
ⓘ
pioneering work in RNA interference therapeutics ⓘ |
| languageOfWorkOrName | English ⓘ |
| notableFor |
contributions to the mechanism of RNA interference
ⓘ
development of RNAi-based therapeutics ⓘ early academic research on RNA interference ⓘ helping establish RNAi as a platform for human therapeutics ⓘ |
| researchInterest |
microRNA
ⓘ
post-transcriptional gene regulation ⓘ small interfering RNA ⓘ |
| workLocation |
United States
ⓘ
linked to:
United States of America
|
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Phil Zamore Description of subject: Phil Zamore is a molecular biologist and biotechnology entrepreneur best known as a co-founder of Alnylam Pharmaceuticals and a pioneer in the field of RNA interference therapeutics.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.